Annual drug update: 2011 in review.
Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice.
Trauma Intensive Care Unit, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA, USA.
Jennifer M
JM
Belavic
D000069594:Abatacept; D000617:Aminoglycosides; D002219:Carbamates; D017277:Drug Approval; D005283:Fentanyl; D000077732:Fidaxomicin; D006801:Humans; D018796:Immunoconjugates; D007189:Indans; D000069476:Linagliptin; D010655:Phenylenediamines; D011392:Proline / Q000031:analogs & derivatives; D011687:Purines; D011799:Quinazolines; D015363:Quinolones; D014481:United States; D014486:United States Food and Drug Administration
D000617:Aminoglycosides; D002219:Carbamates; D018796:Immunoconjugates; D007189:Indans; D010655:Phenylenediamines; D011687:Purines; D011799:Quinazolines; D015363:Quinolones; C101866:ezogabine; D000069476:Linagliptin; D000069594:Abatacept; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; C510790:indacaterol; D011392:Proline; D005283:Fentanyl; D000077732:Fidaxomicin